8th – 9th November 2010, Boston, USA

Organised By

Maintaining patient safety and securing the supply chain

To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/anti-counterfeiting

Scott LaGanga, Executive Director, Partnership for Safe Medicines

Lorne M Lipkus, Partner, Kestenberg Siegal Lipkus LLP

Robert Celeste, Director, Healthcare, GS1 US

Andres Diaz Cote, President, Figurazione

Steve Wood, President & CEO, Covectra

Sharon Flank, CEO, InfraTrac

Philip Payne, Investigative Partner, RSSL

Jim Williams, Founder & Chief Scientist, Polyonics

Key Speakers

BOOK NOW!

Anti-Counterfeiting Americas

Driving the Industry Forward | www.futurepharmaus.com

Media Partners

Conference IntroductionAnti-Counterfeiting Americas

8th - 9th November 2010, Boston, USA

DearColleague, Increasing efforts are being made to protect the national supply chain for medicines

distribution. In the US, the pharmaceutical supply chain involves the daily delivery ofapproximately13millionprescriptionproductstopharmacies,hospitals,clinicsandotherhealthcareproviderlocations(Source:UrchPublishing,July2009).

Visiongain’sAnti-CounterfeitingAmericasconferencewillprovidevaluableinsights,intothelatestissuesandtrackandtracepackagingtechnologiesshapingthefieldsofsecurityand supply chain management, with leading experts presenting the best-practices ontacklingpharmaceuticalcounterfeitingandfraud,improvingtheintegrityofdistributionchannelsandrelationshipsbetweenkeyparties.

By attending the Anti-Counterfeiting Americas conference delegates will gain acomprehensiveunderstandingofthisrapidlychangingsector,fromthecomplexstructureof thesupplychain, to thegrowth inmailorderandonlinepharmacies.Thepotentialfor investment in the pharmaceutical logistics market remains high.The FDA has putadditional focus on “corporate responsibility” for supply-chain management, andincreasedvigilanceandactionisneededduetotheriseofcounterfeitdrugsintheglobalsupply chain. Anti-counterfeiting initiatives discussed include the use of technology-based measures, repackaging, consumer education, and increased collaboration withdomesticandinternationallawenforcementagencies.

Byattendingthisconferenceyouwill: •Measuretheimpactofcounterfeitdrugsbyusingapatientcentricapproach •Understand the development process necessary to ensure an effective security

strategy •Improveinventorycontrol •HearchangesintheUSFDAandEuropeanpolicies •Develop global standards to increase patient safety and elevate supply chain

integrity •Learnaboutleveragingsupplierauditsthroughoutaglobalorganization •Understand thechallengesof theglobal traceabilityandserialization regulatory

environment •Utilizeauto-IDadvancementsinpackagingtechnologies •Hearthelateststrategiesfordefendingyourbrandandpursuingoffenders •DevelopworkingrelationshipswithUSlawenforcementauthorities •Balancetheneedfortamper-proofpackagingwithstreamliningyoursupplychain •Evaluatecurrentmethodsforthedetectionofcounterfeitmedicines •Bepartofauniquenetworkingopportunity Ilookforwardtomeetingyouattheconference Bestregards

Maninder Paul Conference Producer

Target Audience:•Pharmaceuticalmanufacturinganddistributingcompanies•Drugwholesalers•Publichealthandregulatorybodies•Legalfirms•Customsandborderagencies•Pharmaceuticalpackagingandlabellingcompanies•Anti-counterfeitingtechnologyandservicesuppliers•Pharmaceuticalspecialistcouriers•Anti-counterfeitingorganizations•Contractmanufacturingorganizations(CMOs)•Retailpharmacychains•Non-governmentalhealthcareorganizationsandAcademia

Who should attend:ChiefSecurityOfficers,VPs,directors,heads,managersandspecialistsof:•Supplychain/SupplyChainSecurity/SupplyChainSystems/GlobalSupplyChain•Anti-counterfeitProjects/Anti-counterfeitingOperations•Distribution/Logistics•Security/GlobalSecurity•Packaging&Labelling•BrandProtection•LegalCounsel•RegulatoryAffairs/IntellectualProperty•QualityAssurance/QualityControl•Compliance•Informationsystems•Informationsystem

Sponsorship and exhibition opportunities:

Thiseventoffersauniqueopportunitytomeetanddobusinesswithsome

ofthekeyplayersinthepharmaceuticalandbiotechindustries.Ifyouhave

aserviceorproducttopromote,youcandosoatthiseventby:

•Hostinganetworkingdrinksreception

•Takinganexhibitionspaceattheconference

•Advertisinginthedelegatedocumentationpack

•Providingbrandedbags,pens,gifts,etc.

Ifyouwould likemore informationontherangeofsponsorshiporexhibition

possibilities for visiongain's Pharmaceutical Anti-counterfeiting Americas

Conference,pleasecontactus:

RonaldReyesMagali:+44(0)2075499934

ronald.magali@visiongainglobal.com

JohnChangkarn:+442075499968

john.changkarn@visiongainglobal.com

Media Partners:PharmiWeb.comistheleadingindustry-sponsoredportalforthepharmaceuticalsector. Supported by most of the leading pharmaceutical corporations,

PharmiWeb.comprovidesdynamicreal-timenews,features,eventslistingsandinternationaljobstoindustryprofessionalsacrossEuropeandtheUS.

For further information please email: corporate@pharmiweb.comBIOTECHNOLOGYEUROPEisownedbyBIOTECHNOLOGYWORLD.ItisbasedandlocatedinWarsaw,Poland.BiotechnologyWorldwasfoundedin2007toprovide

theworld’sbiotechandpharmainformationandmarkettomakeituniversallyaccessibleandusefulforscientificandbusinessprocesses.ItsfirststeptofulfillingthatmissionwasbuildingtheBIOTECHNOLOGYEUROPEplatformthatwillallowaquickspreadof informationindifferentchannels.BIOTECHNOLOGYEUROPEofferscompaniescompletedinternetpublicrelations,publicationandmarketingsolutions.OneofthemainsgoalsofBIOTECHNOLOGYEUROPEistointegratetheBiotechandPharmaSectorinEuropetoglobalbiotechnology,pharmaceuticalandlifescienceactivities.

For further information please visit www.biotechnology-europe.comFuture Pharmaceuticals has forgedpowerful relationshipswith key industryleaderstoprovideaplatformforsuccessfulbrandrecognition,andforsenior

decision-makerstohavethemeanstoprocureandplanimplementationstrategiesbasedonthetopicscovered.Positioned tobeanauthoritative resourcewithin toppharmacompaniesaswellassmall,specialty,andbiotech,FuturePharmaceuticalsmagazineisgearedtocreateadeeppenetrationintoahighlytargetedandresponsiveaudience,bridgingthegapbetweentheindustries’topissuesandthesolutionstop-tiervendorscanprovide.

For further information please visit: www.futurepharmaus.comInPharm is the online platform for exclusive pharmaceutical news, comment,contracts,services,jobsandeventsandishometoInPharmjobs.com,Pharmafile

andPharmafocus.

For further information please visit: www.In-Pharm.comPharma Connections Worldwide® is the leading professional businessnetworking website focused in the Pharmaceutical, Biotechnology and Life

Sciencesresearchindustry.Ourgoalistoprovideaconduitfordeliveryofpremierecontentcoupledwith the right clientele in order to facilitate business development opportunities among industryprofessionalsresponsibleformakingkeydecisionsinaglobalmarketplace.

For further information please visit: www.pharmaconnections.comThe Partnership for Safe Medicines is a coalition of more than 50 patient,physician,pharmacist,university,industryandotherprofessionalorganizations

around the world committed to the safety of prescription drugs and protecting consumers againstunapproved,counterfeit,substandard,mishandledorotherwiseunsafemedicines.

For further information please visit: www.safemedicines.org/

Driving the Industry Forward | www.futurepharmaus.com

Day 1Anti-Counterfeiting Americas Monday 8th November 2010

09:00 Registration and refreshments

09:30 Opening address from the chair

LorneMLipkusPartnerKestenbergSiegalLipkusLLP

09:40 The business value of product serialization within the pharmaceutical supply chain

AcrosstheU.S.pharmaceuticalsupplychain,organizationsarealigningthemselvestoenablemoreeffectiveproductserializationandincreasedvisibilityusingnewstandards.WithwidespreadserializationcomestremendousopportunityforpharmaceuticalmanufacturesandtheirtradingpartnerstoleveragenewstandardsforincreasedefficiencyandgreaterROI.Inthissession,theGS1HealthcareUSorganization,theUSimplementationarmoftheleadingstandards-settingbodyforproductidentification,illustratesthebusinessvalueofserializationandpedigree/visibilityinformation.

•GS1EPCISstandardasapathwaytosignificantpotentialbusinessvalue

•ThestatusofadoptionofGLNandGTINinpharma

•Theindustrystatusforusingserialdatatomatchproduct

•Howserializationcanprovideenormousvisibilityintothesupplychain

•Updateonthe2015readinessprogram(preparingforserializationandpedigreewithintheUS)

RobertCelesteDirector,HealthcareGS1US

10:20 Forging strategic partnerships to elevate product integrity

•Industrytrends

•Developingandapplyingariskmanagementprocess

•Assessingqualifications

•Transitioningaqualifiedvendorintoastrategicpartner

•Casestudy

MikeLewisBusinessDevelopmentManagerSentryBioPharmaServices

11:00 Morning refreshments

11:20 Securing pharmaceuticals against counterfeiting: Assessing latest protection technologies

•Latestdevelopmentsinanti-counterfeitingtechnologies

•Packaged-basesvson-productsolutions

•Designingacomprehensiveanti-counterfeitingstrategy

FrankSchurgersManagingDirectorIntegris

12:00 Counterfeiting in developing countries: The use of mixed technology

•Externalcontrolinmassiveconsumeproducts

•The‘umbrellabrand’concept:Theperfectattack

•Internalcontrolinmassiveconsumerproducts

•Thecolombiacase

•Resultsandrealbenefits

AndresDiazCotePresidentFigurazione

12:40 Networking lunch

13:40 Protecting IP rights •Trademarksandidentitypreservation

•Historyofbrandingandqualityassurance

•Causesofcounterfeiting

•Anti-counterfeitingtechnologyandchoice

14:20 Track and Trace at the WIP manufacturing level •Overviewforanalyzingtradeoffsbetweenbrandprotectiontechnologies

•Whyisinformationregardingauthenticationofproductsandtheirmovementcritical?

•“Pre-adaption”ofpharmaceuticalmanufacturerstoincorporatebrandauthenticationasanintegralpartoftheirexistingoperations

JimWilliamsFounder&ChiefScientistPolyonics

15:00 Afternoon refreshments

15:20 Illegal internet pharmacies: A framework for coordinated action and cooperation

•Illegalinternetpharmacies:Extentoftheproblem

•Actionagainstillegalinternetpharmacies:Whathasbeendone?

•Whatremainstobedone:Theneedforadditionalaction

16:00 Supporting safe medicines strategies in

developing countries •Whichdevelopedcountriesarethemostsusceptibledestinationmarkets

forcounterfeitdrugs?

•Assessingthescaleandeconomiccostofcounterfeiting

•Discusstheroleofdrugregulationsandlawenforcement

•Cooperationwithnational&internationalagencies

TomWoodsPresidentWoodsInternational

16:40 Closing remarks from the chair

16:50 Networking drinks

Take your discussions further and build new relationships in a relaxed and informal setting.

Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2010

Day 2Anti-Counterfeiting Americas

Tuesday 9th November 2010

09:00 Registration and refreshments

09:30 Opening address from the chair

09:40 Cost-effective anti-counterfeiting solutions for the second tier

•Repackagingandcounterfeiting

•Technologies

•Evaluatepackaging-basedandproduct-basedanti-counterfeitingmeasuresbycost,complexity,andeffectivenessforsecondtierproducts

SharonFlankCEOInfraTrac

10:20 Protecting medicines from diversion and counterfeiting

•Amulti-layeredapproachforbrandprotection

•Specialtydistributionasatoolforcombatingdiversion

•Usingsmartphonesandmobilephonesinbrandintegrityandloyaltyprograms

SteveWoodPresident&CEO

Covectra

11:00 Morning refreshments

11:20 Combating pharmaceutical anti-counterfeiting from a legal perspective

•Relationshipbetweenparalleltradeandcounterfeiting

•Basicframeworkfortheparalleltradeofpharmaceuticals

•Recentandfuturedevelopments

12:00 Balancing the need for tamper-proof packaging with streamlining your supply chain

•Costtomanufacturers

•Choosingtherighttamper-evidentpackagingforyourproduct

•Thesmartersupplychainofthefuture

12:40 Networking lunch

13:40 Detecting pharmaceutical counterfeiting

•Stagesofinvestigation

•Investigationanddetectionofcontaminationinpharmaceuticalproducts

•QCandGMPtechniques

PhilipPayneInvestigativePartnerRSSL

14:20 Case study: Utilizing forensic analysis in support of counterfeit investigations

Thepresentationwilllookatvariousstrategiestoutilizeforensicevidenceforcarryingoutcounterfeitinvestigations

VaughnVolpiPresidentPICA

15:00 Afternoon refreshments

15:20 The global impact of fake medicine

•Overviewofthecounterfeitdrugs:Someexamples

•Howfakemedicinesharmpatientsandpublic

•BuildingaCoalition:Acalltoaction

ScottLaGangaExecutiveDirectorPartnershipforSafeMedicines

16.00 Protecting profits and patient safety through implementing new technologies

•Preventativetechnologies

•Authenticationtechnologies

•Track&Tracetechnologies

16:40 Chair’s closing remarks

16:50 End of conference

Howtobook

Email:conferences@visiongainglobal.comWeb:http://www.visiongain.com/anti-counterfeiting

UK Offi ce:Tel: +44(0)2073366100Fax:+44(0)2075499932

VisiongainLtdBSGHouse226-236CityRoadLondonEC1V2QYUK

GeneralinformationVenue:TBA

Payment terms:Visiongainrequirethefullamounttobepaidbeforetheconference.VisiongainLtdmayrefuseentrytodelegateswhohavenotpaidtheirinvoiceinfull.Acreditcardguaranteemayberequestedifpaymenthasnotbeenreceivedinfullbeforetheevent.VisiongainLtdreservestherighttochargeinterestonunpaidinvoices.

Substitutions/name changes or cancellations: Thereisa50%liabilityonallbookingsoncemade,whetherbypost,fax,emailorweb.Thereisanorefundpolicyforcancellationsreceivedonorafteronemonthbefore thestartof theevent.Shouldyoudecide tocancelafter thisdate, thefullinvoicemustbepaid.Conferencenoteswillthenbesenttoyou.Unfortunately,weareunabletotransferplacesbetweenconferencesandexecutivebriefings.However, ifyoucannotattendtheconference,youmaymakeasubstitution/namechangeatanytime,aslongasweareinformedinwritingbyemail,faxorpost.Namechangesandsubstitutionsmustbefromthesamecompanyororganisationandarenottransferablebetweencountries.

Invoice alterations:Therewillbeanadministrationchargeof£50foranychangestoaninvoice,excluding substitutions/name changes, requested by the customer. This will be charged to thecustomerbycreditcardpriortothechangesbeingmade.

Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executivebriefingcontent,timing,speakersorvenuewithoutnotice.TheeventmaybepostponedorcancelledduetounforeseeneventsbeyondthecontrolofvisiongainLtd.Ifsuchasituationarises,wewilltrytorescheduletheevent.However,visiongainLtdcannotbeheldresponsibleforanycost,damageorexpenses,whichmaybeincurredbythecustomerasaconsequenceoftheeventbeingpostponedorcancelled.Wethereforestronglyadviseallourconferenceclientstotakeoutinsurancetocoverthecostoftheregistration,travelandexpenses.

Data Protection: Visiongain Ltd gathers and manages data in accordance with the DataProtectionAct1988.YourpersonalinformationcontainedinthisformmaybeusedtoupdateyouonvisiongainLtdproductsandservicesviapost,telephone,faxoremail,unlessyoustateotherwise.Wemayalsoshareyourdatawithexternalcompaniesofferingcomplementaryproductsorservices.Ifyouwishforyourdetailstobeamended,suppressedornotpassedontoanyexternalthirdparty,pleasesendyourrequesttotheDatabaseManager,visiongainLtd,BSGHouse,226-236CityRoad,London,EC1V2QY.Alternatively,youcanvisitourwebsiteatwww.visiongain.comandamendyourdetails.Pleaseallowapproximately30daysforyourremovalorupdaterequesttobeappliedtoourdatabase.Followingyourremovalorupdaterequest,youmayreceiveadditionalpiecesofcommunicationfromvisiongainLtdduringthetransitionalperiod,whilstthechangesarecomingintoeffect.

Fee: Theconferencefeeincludeslunch,refreshmentsandconferencepapersprovidedontheday.This feedoesnot include travel, hotel accommodation, transfersor insurance, (whichwe stronglyrecommendyouobtain).

VAT: VATwillbechargedatthelocalrateoneachconference.DelegatesmaybeabletorecoverVATincurredbycontactingEurocashCorporationplc+44(0)1273325000,eurocash@eurocashvat.com.Eurocashspecialiseinrecoveringcross-borderVAT.

How we will contact you: VisiongainLtd’spreferredmethodofcommunicationisbyemailandphone.Pleaseensurethatyoucompletetheregistrationforminfullsothatwecancontactyou.

UnabletoattendObviouslynothingcomparestobeingtherebutyouneednotmissout.Simplyticktheboxandsendwithyourpayment.YouwillreceiveyourcopyoftheeventCDRomtwoweeksaftertheevent.

Yes, please send me a copy of the CD for Price£550 VAT:£96.25 Total:£646.25

Officeuseonly

Formultiplebookings

Photocopythisform Conf.codeVG

StandardPricesConference only Fee: £1299 (USD 1892*)

*USDpriceisestimateonly

PromotionalLiteratureDistributionDistribution of your company’s promotional literature to all conference attendees

Fee: £999 VAT: £174.83 Total: £1173.83

Details

Forename: Surname:

JobTitle: Company:

MainSwitchboardNumber:

Address:

Country: Postcode:

Phone: Fax:

Email:

Signature:

IconfirmthatIhavereadandagreetothetermsandconditionsofbooking

Methodsofpayment

Paymentmustbemadeinsterling

By Mail: Completeandreturnyoursignedregistrationformtogetherwithyourchequepayable

toVisiongainLtdandsendto:visiongainLtd,BSGHouse,226-236CityRoad,London,EC1V2QY,UK

By Fax: Completeandfaxyoursignedregistrationformwithyourcreditcarddetails

to+44(0)2075499932

By Phone:Calluson+44(0)2073366100withyourcreditcarddetails

By Credit Card:Fillinyourcarddetailsbelowandfaxbackto+44(0)2075499932

By Bank Transfer:

VisiongainLtd A/C:visiongainLtd

BarclaysBank SortCode:20-71-64

PiccadillyBranch AccountNo:60387118

48RegentStreet SwiftCode:BARCGB22

London,W1B5RA IBAN:GB80BARC20716460387118

Please debit my credit card:

Access MasterCard Visa AmericanExpress

Cardnumber:

ExpiryDate:

Securitynumber(last3digitsonbackofcreditcard):

Signature:

Cardholder’sname:

Newsupdates

Pleasetickifyoudonotwanttoreceiveemailnewsupdatesinthefuture

Registration FormAnti-Counterfeiting Americas

8th - 9th November 2010, Boston, USA

www.visiongain.com/anti-counterfeiting

Anti-Counterfeiting Americas

8th - 9th November 2010Boston, USA